News

A paper published by Straight Lab members (Rae Brown, Jacob Schwartz) find that Xenopus M18BP1 phosphorylation controls its centromere localization in interphase and metaphase, such that this phosphoregulatory switch restricts CENP-A nucleosome assembly to interphase.

Geneticist William Greenleaf, PhD, and biochemist Rhiju Das, PhD, gathered insights from citizen scientists via a Stanford Medicine-designed video game to help create an affordable RNA sensor for tuberculosis.

Science Communication Lab (formerly iBiology) presents Life Recombined, a new short film exploring the origins of recombinant DNA and the groundbreaking contributions of Paul Berg and Janet Mertz.

Professor Khosla is being honored for his contributions to the enzymology of polyketide synthesis and Celiac Disease.

Dr. Flora Rutaganira, Assistant Professor of Biochemistry and of Developmental Biology, has been awarded the 2025 Dr. Laure Aurelian Biomedical Research Award!

A joint paper from Konermann Lab and Arc Institute collaborators introduce RESPLICE, an RNA-guided trans-splicing platform.

Dr. I. Robert Lehman’s work focuses on DNA replication and repair, and he had identified two enzymes that play critical roles in these processes.

Recent research from the Brandman Lab (Danish Khan, Ananya Vinayak, Cole Sitron, and Onn Brandman) reveals a new force-based mechanism for quality control of stalled ribosomes. CAT tailing is a conserved, non-templated process that extends stalled nascent polypeptide chains while they are still attached to the large ribosomal subunit.

Deadline is March, 2026. Hidden leaderboard targets now include cryo-EM structures of new-to-Nature RNA folds, RNA complexes with small molecules and proteins, and assemblies up to 6000 nts, solved in collaboration with the AI@HHMI initiative at Janelia Research Center and experimental groups around the world.

PDB’s first 2026 “Molecule of the Month” are natural RNA-only assemblies discovered by Rachael Kretsch, Postdoctoral Scholar in Das Lab!

The goal is to develop vaccines against the deadly Ebola, Marburg and related viruses, including those that have yet to emerge.

A study in mice suggests that reducing enzyme activity could prevent cell death in patients with a type of Parkinson’s disease.

Paul Sigala was named a recipient of the 2025 Spencer Fox Eccles School of Medicine Warren and Jessica Cannon Research Excellence/Impact Award.